Department of Radiation Biosciences, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba 278-0022, Japan.
Department of Environmental Health, Faculty of Pharmaceutical Sciences, Tokyo University of Science, 2641 Yamazaki, Noda-shi, Chiba 278-0022, Japan.
Toxicol Appl Pharmacol. 2020 Nov 15;407:115240. doi: 10.1016/j.taap.2020.115240. Epub 2020 Sep 14.
Agents that promote DNA repair may be useful as radioprotectants to minimize side effects such as radiation pneumonia caused by damage to normal cells during radiation therapy to treat lung cancer. We have reported that extracellular nucleotides and nucleosides are involved in the P2 or P1 receptor-mediated DNA damage response (DDR) after γ-irradiation. Here, we investigated the effects of ATP, UTP, GTP, ITP and their metabolites on the γH2AX/53BP1 focus formation in nuclei (a measure of γ-irradiation-induced DDR) and the survival of γ-irradiated immortalized human bronchial epithelial (BEAS-2B) cells. Fluorescence immunostaining showed that ATP and ADP increase DDR and DNA repair, and exhibit radioprotective effects as evaluated by colony formation assay. These effects of ATP or ADP were blocked by inhibitors of P2X7 or P2Y12 receptor, respectively, and by ERK1/2 inhibitor. ATP and ADP enhanced phosphorylation of ERK1/2 by suppressing MKP-1 and MKP-3 expression after γ-irradiation. These results indicate that ATP and ADP exhibit radioprotective effects by phosphorylation of ERK1/2 via activation of P2X7 and P2Y12 receptors, respectively, to promote γ-irradiation-induced DDR and DNA repair. ATP and ADP appear to be candidates for radioprotectants to reduce damage to non-cancerous cells during lung cancer radiotherapy by promoting DDR and DNA repair.
促进 DNA 修复的药物可用作放射防护剂,以减轻副作用,如肺癌放射治疗中因正常细胞受损导致的放射性肺炎。我们曾报道,细胞外核苷酸和核苷参与 γ 射线照射后 P2 或 P1 受体介导的 DNA 损伤反应 (DDR)。在此,我们研究了 ATP、UTP、GTP、ITP 及其代谢物对 γH2AX/53BP1 核内焦点形成(γ 射线诱导 DDR 的衡量标准)和 γ 射线照射永生化人支气管上皮 (BEAS-2B) 细胞存活的影响。荧光免疫染色显示,ATP 和 ADP 增强 DDR 和 DNA 修复,并通过集落形成测定评估表现出放射防护作用。ATP 或 ADP 的这些作用分别被 P2X7 或 P2Y12 受体抑制剂和 ERK1/2 抑制剂阻断。ATP 和 ADP 通过抑制 γ 射线照射后 MKP-1 和 MKP-3 的表达来增强 ERK1/2 的磷酸化。这些结果表明,ATP 和 ADP 通过激活 P2X7 和 P2Y12 受体分别使 ERK1/2 磷酸化,从而表现出放射防护作用,以促进 γ 射线诱导的 DDR 和 DNA 修复。ATP 和 ADP 似乎是通过促进 DDR 和 DNA 修复来减少肺癌放射治疗中对非癌细胞损伤的放射防护剂的候选物。